NEW YORK (GenomeWeb News) – Roche announced today that it is investing 215 million Swiss francs ($191.7 million) in expanding its research, development, and production operations in Germany for its Applied Science and Professional Diagnostics businesses.
The money will be used to construct a multi-purpose building for Roche Diagnostics in Penzberg, near Munich, the firm said. From around mid-2010, the complex is expected to manufacture products ranging from biotech constituents for immunodiagnostics and life sciences research through complete immunodiagnostic test kits, which are used worldwide on Roche’s Cobas and Elecsys instruments.
The firm said that the expansion of production capacity for its Applied Science business is a reaction to “the sustained growth in demand for research reagents, including LightCycler real-time PCR systems.”